One strategy for mapping disease loci using marker-disease associations is
to test for association with case-control samples and follow up a positive
result with a family-based test. Using a family-based test in the second st
age can help provide protection against false-positive results that can res
ult from use of inappropriate controls and provides assurance that associat
ion identified in the first stage is occurring between linked loci. It is c
rucial for this two-stage strategy that the first stage be as powerful as p
ossible to detect association since only positive results are tested in the
second stage. In certain situations, the power of the first-stage test can
be increased by combining the case-control and family data. However, this
introduces correlation between the first- and second-stage tests, and treat
ing them as independent tests causes a bias. Here we propose a Monte Carlo
method that accounts for the correlation and provides the correct significa
nce level for the second-stage test. We also discuss the use of a two-stage
procedure when doing a genome scan for the data presented in the Genetic A
nalysis Workshop 9 study. Genet. Epidemiol. 18:48-62, 2000. (C) 2000 Wiley-
Liss, Inc.